Differential gene expression pattern of diabetic rat retinas after intravitreal injection of erythropoietin.
BACKGROUND
To profile the pattern of gene expression in diabetic rat retinas with or without intravitreal injection of erythropoietin.


METHODS
By using streptozotocin-induced diabetic rats, after intravitreal injection of erythropoietin, neurosensory retinas were collected to determine the effect of erythropoietin on gene expression.


METHODS
Three groups of Sprague-Dawley rats were studied: normal control (15), diabetic rats with saline injection (15) and diabetic rats with intravitreal erythropoietin treatment (15).


METHODS
Diabetes was induced by intra-peritoneal injection of streptozotocin. Intravitreal injection of erythropoietin was performed at the following time points: 0, 30 and 120 days after diabetes onset. Four days after each injection at above-mentioned time points, the retinas were harvested for microarray assay. The real-time PCR was used to evaluate the microarray data.


RESULTS
Genes encoding inflammatory factors, such as interleukin-2 and interleukin-11, which were upregulated in the diabetic retinas, were restored after erythropoietin treatment. Genes encoding pro-apoptotic effectors, like Tnfrsf5, Bid3 and Bcl2l1, were also upregulated in diabetic rats and attenuated in erythropoietin-treated group. In addition, real-time PCR were employed to confirm the changes of the genes Trex2, G1P2, DHX58, RGD1311906 and LOC689064, which have not been reported in diabetic retinopathy.


CONCLUSIONS
Intravitreal erythropoietin treatment is able to normalize the gene expression responsible for pro-apoptotic and inflammatory responses noted in diabetic retinas.
Laboratory of Clinical Visual Sciences, Institute of Health Sciences, Shanghai JiaoTong University School of Medicine and Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Qing
Q
Chu
Jingfa
J
Zhang
Yalan
Y
Wu
Yu
Y
Zhang
Guoxu
G
Xu
Weiye
W
Li
Guo-Tong
GT
Xu
D000818:Animals; D017931:DNA Primers; D003921:Diabetes Mellitus, Experimental / Q000235:genetics*; D003930:Diabetic Retinopathy / Q000235:genetics*; D004921:Erythropoietin / Q000008:administration & dosage*; D005136:Eye Proteins / Q000235:genetics*; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects*; D058449:Intravitreal Injections; D008297:Male; D040081:Protein Array Analysis; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction
D017931:DNA Primers; D005136:Eye Proteins; D012333:RNA, Messenger; D004921:Erythropoietin